Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Multitasking by pVHL in tumour suppression.

Ian J Frew1, Wilhelm Krek

  • 1Institute of Cell Biology, ETH Zurich, 8093 Zurich, Switzerland.

Current Opinion in Cell Biology
|November 17, 2007
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Hypoxia shapes both therapeutic response and resistance in metastatic clear cell renal cell carcinoma.

Cancer cell·2026
Same author

Pharmacologic and Oncohistone Inhibition of SETD2 Converge on Genomic Instability.

Cancers·2026
Same author

Novel Syngeneic Cell Lines for Studying High-Risk BRAFV600E-Driven Colorectal Cancer In Vivo.

Cancer research communications·2026
Same author

Versatile roles of annexin A4 in clear cell renal cell carcinoma: Impact on membrane repair, transcriptional signatures, and composition of the tumor microenvironment.

iScience·2025
Same author

KDM5C and KDM5D mutations have different consequences in clear cell renal cell carcinoma cells.

Communications biology·2025
Same author

Nonstop mutations cause loss of renal tumor suppressor proteins <i>VHL</i> and <i>BAP1</i> and affect multiple stages of protein translation.

Science advances·2025
Same journal

Mechanosensing in immune cells: Implications for migration and beyond.

Current opinion in cell biology·2026
Same journal

Emerging role of organelles in cell migration.

Current opinion in cell biology·2026
Same journal

Nuclear adaptation in cell migration.

Current opinion in cell biology·2026
Same journal

Patterns in motion: Choreographing dynamic cell behaviours during tissue repair.

Current opinion in cell biology·2026
Same journal

Quo vadis reconstituted cell surfaces? Purpose and future perspectives for minimal systems of the cell plasma membrane.

Current opinion in cell biology·2026
Same journal

Nuclear determinants of mRNA and protein isoforms.

Current opinion in cell biology·2026
See all related articles

The von Hippel-Lindau (VHL) tumor suppressor gene product, pVHL, is crucial for preventing cancer by regulating hypoxia-inducible factors (HIFs) and other cellular processes. VHL inactivation disrupts these functions, contributing to tumor initiation and progression.

Area of Science:

  • Oncology
  • Molecular Biology
  • Cell Biology

Background:

  • The von Hippel-Lindau (VHL) tumor suppressor gene product, pVHL, is known to destabilize hypoxia-inducible factor alpha (HIFalpha) subunits, a key part of the hypoxia signaling pathway.
  • Inactivation of pVHL is a known cause of human cancers.
  • Emerging evidence suggests pVHL also regulates HIFalpha-independent processes critical for tumor suppression.

Purpose of the Study:

  • To explore the multifaceted roles of pVHL in cancer, beyond its established function in hypoxia signaling.
  • To investigate the HIFalpha-independent cellular processes controlled by pVHL.
  • To understand how VHL inactivation cooperates with other cancer pathways in tumor initiation.

Main Methods:

  • Review of existing literature on VHL function and cancer biology.

Related Experiment Videos

  • Analysis of studies investigating pVHL's role in microtubule dynamics, primary cilia, cell proliferation, apoptosis, DNA damage response, and extracellular matrix deposition.
  • Examination of research on cooperating cancer pathways involved in VHL-mutated tumors.

    • Main Results:

    • pVHL's tumor suppressive functions extend to regulating microtubule dynamics, primary cilium maintenance, cell proliferation, neuronal apoptosis, extracellular matrix deposition, and DNA damage responses.
    • Tumorigenesis often requires VHL mutation in conjunction with alterations in other cancer-related signaling pathways.
    • pVHL influences a broad spectrum of cellular functions essential for maintaining cellular homeostasis and preventing malignant transformation.

    Conclusions:

    • pVHL plays a critical role in cancer suppression through both HIFalpha-dependent and HIFalpha-independent mechanisms.
    • Understanding the complete network of pVHL-controlled cellular processes is essential for comprehending its tumor suppressive functions.
    • Disruption of these intricate signaling networks by VHL inactivation contributes significantly to cancer development, highlighting potential therapeutic targets.